Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksARDN.L Regulatory News (ARDN)

  • There is currently no data for ARDN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

20 Mar 2019 07:00

RNS Number : 3317T
Arden Partners plc
20 March 2019
 

Arden Partners plc

("Arden" or the "Company")

 

Annual General Meeting Statement 2019

 

 Arden Partners plc (AIM: ARDN), the institutional stockbroking company, will hold its Annual General Meeting ("AGM") at 12.30 pm today at 125 Old Broad Street, London EC2N 1AR.

 

The following statement will be made at the AGM:

 

"As predicted in the 2018 Annual Report, market conditions have remained challenging and we expect them to continue to be so in the short term.

 

Nevertheless, in the year to date we have completed a number of fundraisings and advisory transactions on behalf of our corporate clients.

 

Furthermore, we have continued to grow our corporate client base which remains key to our strategy.

 

The Company's balance sheet remains strong and despite the market challenges we have a good pipeline of corporate business."

 

For further enquiries:

 

Arden Partners plc

020 7614 5900

Donald Brown - Chief Executive Officer

James Reed-Daunter - Executive Director

Steve Douglas - Group Finance Director

 

GCA Altium Limited

020 7484 4040

Sam Fuller / Tim Richardson

 

 

Notes for editors

 

Arden is a dedicated corporate adviser and multi-service stockbroker to small and mid-cap companies in the UK and their investors.

 

The absolute core of our business is the effective management of the needs of our significant and growing base of corporate clients, and the effective support of their relationships with existing and potential shareholders. 

 

These relationships are enhanced by the quality of our corporate finance advice and industry research, and the strong market presence of our sales and trading teams.

 

Our corporate finance capabilities encompass M&A, corporate finance advisory, broking and Sponsor and NOMAD services. We represent our clients in private transactions and AIM and Main Market share issues.

 

Our research is designed to be sector focused, concentrating on top down thematic trends which highlight companies giving investors an exposure to the real growth areas of the small-cap and AIM markets.

 

It is the job of the sales team to keep institutions abreast of these themes and stock ideas. When there is a requirement for our corporate clients to raise money to fulfil their growth ambitions, the sales team is in a strong position to effect this, with its entrenched relationships with the UK institutional and non-institutional markets.

 

Our market making and trading teams provide liquidity in the shares of our corporate clients. We also trade the shares of non-client corporates on behalf of institutions.

 

The recently added Arden Wealth Management team offers a bespoke discretionary service to our clients, with the ability to trade/invest in equities, bonds and a range of global investment funds.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMUKVURKVAOAAR
Date   Source Headline
5th Apr 201210:23 amRNSForm 8.3 - Arden Partners plc
4th Apr 20124:00 pmRNSForm 8 (OPD) Arden Partners Plc
3rd Apr 201210:57 amRNSForm 8 (OPD) Arden Partners plc
30th Mar 201211:00 amRNSForm 8.3 - Arden Partners (Offeree)
30th Mar 201210:51 amRNSForm 8.3 - Arden partners
29th Mar 201212:46 pmRNSResult of AGM
29th Mar 201211:00 amRNSAGM Statement and Commencement of Offer Period
29th Mar 20127:00 amRNSEBT Disposal and Transfer and TVR
13th Mar 201210:03 amRNSArden Partners strengthens the team
29th Feb 201211:00 amRNSTotal Voting Rights
28th Feb 201211:50 amRNSForm 8.5 (EPT/NON-RI)
27th Feb 201211:50 amRNSForm 8.5 (EPT/NON-RI)
23rd Feb 20126:00 pmRNSAnnual Report and Accounts
22nd Feb 201211:50 amRNSForm 8.5 (EPT/NON-RI)
17th Feb 201211:50 amRNSForm 8.5 (EPT/NON-RI)
10th Feb 201211:50 amRNSForm 8.5 (EPT/NON-RI)
6th Feb 201211:50 amRNSForm 8.5 (EPT/NON-RI)
3rd Feb 201211:50 amRNSForm 8.5 (EPT/NON-RI)
31st Jan 201211:36 amRNSHolding(s) in Company
30th Jan 201210:51 amRNSHolding(s) in Company
27th Jan 20121:04 pmRNSHolding(s) in Company
24th Jan 201211:50 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 201211:56 amRNSForm 8.5 (EPT/NON-RI)
17th Jan 201211:50 amRNSForm 8.5 (EPT/NON-RI)
16th Jan 201211:50 amRNSForm 8.5 (EPT/NON-RI)
30th Dec 201111:54 amRNSDirectorate Change
21st Dec 20117:00 amRNSPreliminary results for the year ended 31 October
3rd Nov 20112:30 pmRNSTrading Update
4th Oct 20114:29 pmRNSDirector's dealing
4th Oct 20112:30 pmRNSTotal Voting Rights
14th Sep 201111:50 amRNSForm 8.5 (EPT/NON-RI)
9th Sep 201111:50 amRNSForm 8.5 (EPT/NON-RI)
8th Sep 201111:50 amRNSForm 8.5 (EPT/NON-RI)
7th Sep 201111:50 amRNSForm 8.5 (EPT/NON-RI)
7th Sep 201111:50 amRNSForm 8.5 (EPT/NON-RI)
7th Sep 201111:50 amRNSForm 8.5 (EPT/NON-RI)
2nd Sep 201111:50 amRNSForm 8.5 (EPT/NON-RI)
1st Sep 201111:50 amRNSForm 8.5 (EPT/NON-RI)
1st Sep 201111:50 amRNSForm 8.5 (EPT/NON-RI)
31st Aug 201111:50 amRNSForm 8.5 (EPT/NON-RI)
30th Aug 201111:50 amRNSForm 8.5 (EPT/NON-RI)
30th Aug 201111:50 amRNSForm 8.5 (EPT/NON-RI)
26th Aug 201111:50 amRNSForm 8.5 (EPT/NON-RI)
25th Aug 201111:50 amRNSForm 8.5 (EPT/NON-RI)
23rd Aug 201111:50 amRNSForm 8.5 (EPT/NON-RI)
23rd Aug 201111:50 amRNSForm 8.5 (EPT/NON-RI)
22nd Aug 201111:50 amRNSForm 8.5 (EPT/NON-RI)
18th Aug 201111:50 amRNSForm 8.5 (EPT/NON-RI)
18th Aug 201111:50 amRNSForm 8.5 (EPT/NON-RI)
15th Aug 201111:50 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.